Goehring & Rozencwajg Associates’s Trilogy Metals TMQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.22M Buy
1,728,153
+319,949
+23% +$1.46M 0.33% 37
2025
Q4
$6.1M Buy
1,408,204
+69,883
+5% +$329K 0.6% 37
2025
Q3
$2.85M Buy
1,338,321
+58,812
+5% +$105K 0.34% 40
2025
Q2
$1.74M Sell
1,279,509
-123,288
-9% -$174K 0.27% 41
2025
Q1
$2.28M Buy
1,402,797
+10,600
+0.8% +$14.6K 0.41% 39
2024
Q4
$1.47M Sell
1,392,197
-277,019
-17% -$249K 0.3% 43
2024
Q3
$827K Sell
1,669,216
-23,900
-1% -$13.2K 0.17% 43
2024
Q2
$866K Buy
1,693,116
+14,300
+0.9% +$6.71K 0.17% 47
2024
Q1
$831K Buy
1,678,816
+31,800
+2% +$14.9K 0.18% 50
2023
Q4
$721K Buy
1,647,016
+47,310
+3% +$21.1K 0.17% 49
2023
Q3
$779K Buy
1,599,706
+46,800
+3% +$23.8K 0.19% 49
2023
Q2
$868K Buy
1,552,906
+144,900
+10% +$81.8K 0.25% 49
2023
Q1
$750K Buy
1,408,006
+34,337
+2% +$20.3K 0.26% 47
2022
Q4
$740K Buy
+1,373,669
New +$801K 0.26% 47

Other funds holding TMQ

Goehring & Rozencwajg Associates's TMQ Position: Q1 2026 in Review

Goehring & Rozencwajg Associates increased its Trilogy Metals (TMQ) stake by 23% in Q1 2026, buying an estimated $1.46M and bringing the position to 1,728,153 shares worth $6.22M. The position accounts for 0.33% of the portfolio, ranked #37.

Goehring & Rozencwajg Associates first reported a position in TMQ in Q4 2022 and has held it in 14 quarters since. 146 funds tracked by Wall St. Rank hold TMQ as of Q1 2026.

  • Goehring & Rozencwajg Associates held 1,728,153 shares of Trilogy Metals worth $6.22M as of Q1 2026.
  • Goehring & Rozencwajg Associates bought 319,949 Trilogy Metals shares in Q1 2026, an estimated $1.46M.
  • Trilogy Metals made up 0.33% of Goehring & Rozencwajg Associates's portfolio in Q1 2026, its #37 holding.
  • Goehring & Rozencwajg Associates first reported a position in Trilogy Metals in Q4 2022 and has held it in 14 quarters since.
  • 146 funds tracked by Wall St. Rank held Trilogy Metals as of Q1 2026.

Based on Goehring & Rozencwajg Associates's 13F filing for Q1 2026, filed 5 May 2026.